Adverse Event Management in HR+/HER2– Advanced Breast Cancer: PI3K/AKT/PTEN Pathway - Episode 8

Best Practices in Managing Patients on Capivasertib

, ,

Panelists discuss the key advice they would offer to fellow physicians, nurse practitioners, advanced practice providers, and pharmacists involved in the care of patients on capivasertib, emphasizing best practices for patient management and communication.

EP. 1: Insights on Biomarker Testing in HR+/HER2- Advanced Breast Cancer
EP. 2: First-Line Treatment Strategies for HR+/HER2- Advanced Breast Cancer
EP. 3: Role of PI3K/AKT/PTEN Pathway in HR+/HER2- Advanced Breast Cancer
EP. 4: Overview of the CAPItello-291 Trial
EP. 5: Clinical Experience with Capivasertib
EP. 6: Adverse Event Management: Strategies for Reducing Diarrhea Risk in Capivasertib Therapy
EP. 7: Managing Capivasertib Side Effects: Strategies for Educating, Monitoring, and Addressing Rash and Hyperglycemia
Now Viewing
EP. 8: Best Practices in Managing Patients on Capivasertib

Video content above is prompted by the following:

  1. All faculty: What advice would you give to fellow physicians, nurse practitioners, advanced practice providers, pharmacists, and other care providers who are involved in the care of patients on capivasertib?

Related Content:

Adverse Event Management in HR+/HER2– Advanced Breast Cancer: PI3K/AKT/PTEN Pathway
Managing Capivasertib Side Effects: Strategies for Educating, Monitoring, and Addressing Rash and Hyperglycemia
Adverse Event Management: Strategies for Reducing Diarrhea Risk in Capivasertib Therapy
Clinical Experience with Capivasertib